G Enrico Rovati
Overview
Explore the profile of G Enrico Rovati including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
1515
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thompson M, Reiner-Link D, Berghella A, Rana B, Rovati G, Capra V, et al.
Crit Rev Clin Lab Sci
. 2024 Aug;
61(8):641-684.
PMID: 39119983
The field of pharmacogenetics, the investigation of the influence of one or more sequence variants on drug response phenotypes, is a special case of pharmacogenomics, a discipline that takes a...
2.
Alexander S, Christopoulos A, Davenport A, Kelly E, Mathie A, Peters J, et al.
Br J Pharmacol
. 2023 Dec;
180 Suppl 2:S23-S144.
PMID: 38123151
The Concise Guide to PHARMACOLOGY 2023/24 is the sixth in this series of biennial publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key properties of...
3.
Camera M, Canzano P, Brambilla M, Rovati G
Front Pharmacol
. 2022 Feb;
13:784214.
PMID: 35211011
Leukotrienes are important pro-inflammatory lipid mediators derived from the arachidonic acid metabolism. In particular, cysteinyl leukotrienes, namely LTC, LTD, and LTE are involved in many of the principal features of...
4.
Sokolowska M, Rovati G, Diamant Z, Untersmayr E, Schwarze J, Lukasik Z, et al.
Allergy
. 2022 Feb;
77(8):2337-2354.
PMID: 35174512
Non-steroidal anti-inflammatory drugs (NSAIDs) and other eicosanoid pathway modifiers are among the most ubiquitously used medications in the general population. Their broad anti-inflammatory, antipyretic, and analgesic effects are applied against...
5.
Alexander S, Christopoulos A, Davenport A, Kelly E, Mathie A, Peters J, et al.
Br J Pharmacol
. 2021 Sep;
178 Suppl 1:S27-S156.
PMID: 34529832
The Concise Guide to PHARMACOLOGY 2021/22 is the fifth in this series of biennial publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key properties of...
6.
Hoxha M, Tedesco C, Quaglin S, Malaj V, Pustina L, Capra V, et al.
Front Pharmacol
. 2021 Feb;
11:611561.
PMID: 33519477
Cysteinyl leukotrienes are proinflammatory mediators with a clinically established role in asthma and a human genetic and preclinical role in cardiovascular pathology. Given that cardiovascular disease has a critical inflammatory...
7.
Sokolowska M, Rovati G, Diamant Z, Untersmayr E, Schwarze J, Lukasik Z, et al.
Allergy
. 2020 Apr;
76(1):114-130.
PMID: 32279330
Eicosanoids are biologically active lipid mediators, comprising prostaglandins, leukotrienes, thromboxanes, and lipoxins, involved in several pathophysiological processes relevant to asthma, allergies, and allied diseases. Prostaglandins and leukotrienes are the most...
8.
Teopompi E, Rise P, Pisi R, Buccellati C, Aiello M, Pisi G, et al.
Front Pharmacol
. 2019 Sep;
10:938.
PMID: 31507425
Cystic fibrosis (CF) is an autosomal recessive disorder, caused by genetic mutations in CF transmembrane conductance regulator protein. Several reports have indicated the presence of specific fatty acid alterations in...
9.
Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain
Kramer J, Woltersdorf S, Duflot T, Hiesinger K, Lillich F, Knoll F, et al.
J Med Chem
. 2019 Aug;
62(18):8443-8460.
PMID: 31436984
The emerging pharmacological target soluble epoxide hydrolase (sEH) is a bifunctional enzyme exhibiting two different catalytic activities that are located in two distinct domains. Although the physiological role of the...
10.
Sala A, Proschak E, Steinhilber D, Rovati G
Biochem Pharmacol
. 2018 Oct;
158:161-173.
PMID: 30315753
Chronic inflammation and pain is a major global health problem, and nonsteroidal anti-inflammatory drugs (NSAIDs) remain the most frequently prescribed drugs and common option for the treatment of inflammatory pain....